Novo Integrated Sciences Other Share Holders Equity 2012-2024 | NVOS

Novo Integrated Sciences other share holders equity from 2012 to 2024. Other share holders equity can be defined as field containing the sum of all current assets that cannot be standardized into another field as well as those that are aggregated by the company because materially, they are too small to list separately.
Novo Integrated Sciences Annual Other Share Holders Equity
(Millions of US $)
2023 $1
2022 $9
2021 $9
2020 $
2019 $
2018 $
2017 $
2016 $
2016 $
2015 $
2014 $-0
2013 $0
2012 $-0
2012 $
2011 $-0
2011 $
Novo Integrated Sciences Quarterly Other Share Holders Equity
(Millions of US $)
2024-05-31 $0
2024-02-29 $0
2023-11-30 $0
2023-08-31 $1
2023-05-31 $1
2023-02-28 $1
2022-11-30 $9
2022-08-31 $9
2022-05-31 $10
2022-02-28 $10
2021-11-30 $10
2021-08-31 $9
2021-05-31
2021-02-28 $0
2020-11-30
2020-08-31
2020-05-31
2020-02-29
2019-11-30
2019-08-31
2019-05-31
2019-02-28
2018-11-30
2018-08-31
2018-05-31
2018-02-28
2017-11-30
2017-08-31
2017-05-31
2017-03-31
2017-02-28
2016-12-31
2016-11-30
2016-09-30
2016-06-30
2016-05-31
2016-03-31
2015-12-31
2015-09-30 $-0
2015-06-30 $-0
2015-03-31 $-0
2014-12-31
2014-09-30 $-0
2014-06-30 $-0
2014-03-31 $0
2013-12-31
2013-09-30 $0
2013-06-30 $-0
2013-03-31 $-0
2012-12-31 $-0
2012-09-30 $0
2012-08-31
2012-06-30 $-0
2012-03-31 $-0
2012-02-29
2011-12-31 $-0
2011-11-30
2011-09-30
2011-08-31 $0
2011-06-30
2011-05-31 $0
2011-03-31
2011-02-28 $0
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $0.001B $0.013B
Novo Integrated Sciences Inc. is a provider of multi-dimensional primary healthcare services and products principally in Canada and the U.S. It deliver or intend to deliver, multidisciplinary primary health care related services and products through the integration of medical technology, advanced therapeutics and rehabilitative science, through its subsidiaries. Novo Integrated Sciences Inc. is based in Bellevue, Washington.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $20.419B 12.35
Quest Diagnostics (DGX) United States $17.788B 18.03
DaVita (DVA) United States $12.272B 15.87
Encompass Health (EHC) United States $10.397B 24.51
Chemed (CHE) United States $8.402B 25.82
Elanco Animal Health (ELAN) United States $6.955B 16.55
RadNet (RDNT) United States $5.364B 127.25
Option Care Health (OPCH) United States $3.826B 18.13
Amedisys (AMED) United States $3.166B 22.54
LifeStance Health (LFST) United States $2.816B 0.00
Addus HomeCare (ADUS) United States $2.313B 27.14
Astrana Health (ASTH) United States $2.305B 36.12
U.S Physical Therapy (USPH) United States $1.434B 37.73
Pennant (PNTG) United States $1.148B 46.42
Aveanna Healthcare Holdings (AVAH) United States $1.127B 0.00
Atai Life Sciences (ATAI) Germany $0.237B 0.00
Daxor (DXR) United States $0.046B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.014B 0.00
Psychemedics (PMD) United States $0.014B 0.00
ATI Physical Therapy (ATIP) United States $0.011B 0.00
Ontrak (OTRK) United States $0.008B 0.00
IMAC Holdings (BACK) United States $0.001B 0.00